RT Journal Article
SR Electronic
T1 Biallelic variants in <em>POPDC2</em> cause a novel autosomal recessive syndrome presenting with cardiac conduction defects and variable hypertrophic cardiomyopathy
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.07.04.24309755
DO 10.1101/2024.07.04.24309755
A1 Nicastro, Michele
A1 Vermeer, Alexa M.C.
A1 Postema, Pieter G.
A1 Tadros, Rafik
A1 Bowling, Forrest Z.
A1 Aegisdottir, Hildur M.
A1 Tragante, Vinicius
A1 Mach, Lukas
A1 Postma, Alex V.
A1 Lodder, Elisabeth M.
A1 van Duijvenboden, Karel
A1 Zwart, Rob
A1 Beekman, Leander
A1 Wu, Lingshuang
A1 van der Zwaag, Paul A.
A1 Alders, Mariëlle
A1 Allouba, Mona
A1 Aguib, Yasmine
A1 Santomel, J. Luis
A1 de Una, David
A1 Monserrat, Lorenzo
A1 Miranda, Antonio M. A.
A1 Kanemaru, Kazumasa
A1 Cranley, James
A1 van Zeggeren, Ingeborg E.
A1 Aronica, Eleonora M.A.
A1 Ripolone, Michela
A1 Zanotti, Simona
A1 Sveinbjornsson, Gardar
A1 Ivarsdottir, Erna V.
A1 Hólm, Hilma
A1 Guðbjartsson, Daníel F.
A1 Skúladóttir, Ástrós Th.
A1 Stefánsson, Kári
A1 Nadauld, Lincoln
A1 Knowlton, Kirk U.
A1 Ostrowski, Sisse Rye
A1 Sørensen, Erik
A1 Vesterager Pedersen, Ole Birger
A1 Ghouse, Jonas
A1 Rand, Søren
A1 Bundgaard, Henning
A1 Ullum, Henrik
A1 Erikstrup, Christian
A1 Aagaard, Bitten
A1 Bruun, Mie Topholm
A1 Christiansen, Mette
A1 Jensen, Henrik K.
A1 Carere, Deanna Alexis
A1 Cummings, Christopher T
A1 Fishler, Kristen
A1 Tøring, Pernille Mathiesen
A1 Brusgaard, Klaus
A1 Juul, Trine Maxel
A1 Saaby, Lotte
A1 Winkel, Bo Gregers
A1 Mogensen, Jens
A1 Fortunato, Francesco
A1 Comi, Giacomo Pietro
A1 Ronchi, Dario
A1 van Tintelen, J. Peter
A1 Noseda, Michela
A1 Airola, Michael V.
A1 Christiaans, Imke
A1 Wilde, Arthur A.M.
A1 Wilders, Ronald
A1 Clur, Sally-Ann
A1 Verkerk, Arie O.
A1 Bezzina, Connie R.
A1 Lahrouchi, Najim
YR 2024
UL http://medrxiv.org/content/early/2024/07/05/2024.07.04.24309755.abstract
AB POPDC2 encodes for the Popeye domain-containing protein 2 which has an important role in cardiac pacemaking and conduction, due in part to its cAMP-dependent binding and regulation of TREK-1 potassium channels. Loss of Popdc2 in mice results in sinus pauses and bradycardia and morpholino knockdown of popdc2 in zebrafish results in atrioventricular (AV) block. We identified bi-allelic variants in POPDC2 in 4 families that presented with a phenotypic spectrum consisting of sinus node dysfunction, AV conduction defects and hypertrophic cardiomyopathy. Using homology modelling we show that the identified POPDC2 variants are predicted to diminish the ability of POPDC2 to bind cAMP. In in vitro electrophysiological studies we demonstrated that, while co-expression of wild-type POPDC2 with TREK-1 increased TREK-1 current density, POPDC2 variants found in the patients failed to increase TREK-1 current density. While patient muscle biopsy did not show clear myopathic disease, it showed significant reduction of the expression of both POPDC1 and POPDC2, suggesting that stability and/or membrane trafficking of the POPDC1–POPDC2 complex is impaired by pathogenic variants in any of the two proteins. Single-cell RNA sequencing from human hearts demonstrated that co-expression of POPDC1 and 2 was most prevalent in AV node, AV node pacemaker and AV bundle cells. Sinoatrial node cells expressed POPDC2 abundantly, but expression of POPDC1 was sparse. Together, these results concur with predisposition to AV node disease in humans with loss-of-function variants in POPDC1 and POPDC2 and presence of sinus node disease in POPDC2, but not in POPDC1 related disease in human. Using population-level genetic data of more than 1 million individuals we showed that none of the familial variants were associated with clinical outcomes in heterozygous state, suggesting that heterozygous family members are unlikely to develop clinical manifestations and therefore might not necessitate clinical follow-up. Our findings provide evidence for POPDC2 as the cause of a novel Mendelian autosomal recessive cardiac syndrome, consistent with previous work showing that mice and zebrafish deficient in functional POPDC2 display sinus and AV node dysfunction.Competing Interest StatementDr. Lorenzo Monserrat is a shareholder in Dilemma Solutions SL. Deanna Alexis Carere is an employee of GeneDx, LLC.Funding StatementWe thank the families for their participation and collaboration. N.L. is supported by the Dutch Research Council (ZonMW VENI and Off-road). C.R.B., A.V.P. and N.L. acknowledge the support from the Dutch Heart Foundation (CVON 2018-30 PREDICT2 and CVON2014-18 CONCOR-GENES to C.R.B.) and the Netherlands Organization for Scientific Research (VICI fellowship, 016.150.610, to C.R.B.). This work was supported in part by the NIH awards R35GM128666 (M.V.A.) and T32GM092714 (F.Z.B.), a Sloan Research Fellowship (M.V.A.), and an American Heart Association Fellowship 23PRE1019634 (L.W.). This study makes use of data generated by the DECIPHER community. A full list of centres who contributed to the generation of the data is available from http://decipher.sanger.ac.uk and via email from decipher@sanger.ac.uk. Funding for the project was provided by the Wellcome Trust. Firth, H.V. et al (2009). DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans using Ensembl Resources. Website: https://www.deciphergenomics.org/. This project has been made possible in part by the Chan Zuckerberg Foundation (2019-202666) to M.N. and the British Heart Foundation and Deutsches Zentrum fur Herz-Kreislauf-Forschung (BHF/DZHK: SP/19/1/34461) to M.N. M.N. and L.M. were supported by the Rosetrees Trust Intermediate Project Grant (PGS23/100028) and NIHR Imperial BRC Cardiovascular Pilot Project Grant. L.M. was further supported by British Heart Foundation Clinical Research Training Fellowship (FS/CRTF/23/24444), British Society for Heart Failure Research Fellowship and Alexander Jansons Myocarditis UK. We thank Drs. Delphine Bichet and Florian Lesage (Universite de Nice Sophia Antipolis, France) for sharing the hTREK-1a plasmid. We thank Drs. Mohamed Hosny and Magdi Yacoub (Aswan Heart Centre, Magdi Yacoub Foundation, Egypt) for reviewing the phenotype of patients recruited at their center. We thank Sara Teichmann for sharing data on scRNA seq in human hearts.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol was approved by the Amsterdam University Medical Center Research Ethics Committee and the local Institutional Review Boards of contributing centers. Signed informed consent was obtained from the patients or their parents.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe pdb coordinates for the POPDC2 homology models are available on request from the authors. All data produced in the present study are available upon reasonable request to the authors